Vaibhavi Shah
CEO
Invengene Limited
This company is a research and development center specializing in the development and manufacturing of injectable pharmaceuticals. They offer a range of injectable formulations, including aqueous, non-aqueous, and lyophilized injections, providing comprehensive solutions for sterile liquid drug products.
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Ankur Shah
CEO
Product
Problem
Developing and manufacturing injectable pharmaceuticals requires specialized expertise and facilities, particularly for complex formulations like lyophilized injections and liposomal technologies. Pharmaceutical companies often face challenges in scaling production, navigating regulatory hurdles, and ensuring consistent quality across diverse product lines.
Solution
Invengene offers end-to-end solutions for injectable pharmaceuticals, from research and development to commercial manufacturing. They provide formulation development, analytical testing, and regulatory affairs support, specializing in complex injectables such as liquid injectables, peptide injectables, liposome injectables, and lyophilized injectables. By leveraging a global network of contract manufacturing organizations (CMOs) and maintaining expertise in advanced drug delivery technologies, Invengene helps partners accelerate product development, ensure regulatory compliance, and achieve efficient scale-up for global markets.
Target Audience
Invengene serves major, specialty, and generic pharmaceutical companies seeking to expand their injectable product portfolios in both emerging and regulated markets.
Features
- Formulation development for a range of injectable types, including aqueous, non-aqueous, emulsions, and suspensions
- Expertise in complex injectables, including liposomal and peptide-based formulations
- Lyophilization capabilities for enhanced drug stability and shelf life
- Analytical development services for method validation and quality control
- Regulatory affairs support for global dossier preparation and submissions across multiple regions
- GMP-compliant scale-up facilities for seamless transition from development to manufacturing
- Strategic alliances with worldwide CMOs to ensure reliable supply chain and scalable production
- Focus on sterile product manufacturing, including pre-filled syringes and vials